Compugen
CGEN
89 hedge funds and large institutions have $70.1M invested in Compugen in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 34 reducing their positions, and 26 closing their positions.
122% more call options, than puts
Call options by funds: $251K | Put options by funds: $113K
4.76% less ownership
Funds ownership: 48.55% → 43.79% (-4.8%)
19% less funds holding
Funds holding: 110 → 89 (-21)
47% less capital invested
Capital invested by funds: $132M → $70.1M (-$62.1M)
53% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 34
73% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 26
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$3.57M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.33M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.08M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$1.08M |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$643K |
CGEN Hedge Fund Activity: Q2 2022 in Review
89 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Compugen (CGEN) for Q2 2022, worth a combined $70.1M — down 47% from $132M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CGEN and 7 opened new positions — a net loss of 19 holders — while 34 trimmed existing stakes and 16 added.
The largest buyer was ARK Investment Management, adding an estimated $1.19M. The largest seller was BlackRock, cutting an estimated $3.57M.
- 89 institutional investors held Compugen (CGEN) as of Q2 2022, down from 110 in Q1 2022.
- Funds reported $70.1M of Compugen stock for Q2 2022, down 47% quarter-over-quarter.
- 7 funds opened new Compugen positions in Q2 2022 and 26 closed out, a net change of -19 holders.
- The largest Compugen buyer in Q2 2022 was ARK Investment Management, an estimated $1.19M added.
- The largest Compugen seller in Q2 2022 was BlackRock, an estimated $3.57M sold.
Based on aggregated 13F filings for Q2 2022.